Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Magnus Ohman

Showing results (11-20 of 511) with videos related to

Pageof 52
Sort By:
JAMA|May 10, 2007
The enigma of drug-eluting stents: hope, hype, humility, and advancing patient careRobert A Harrington, E Magnus Ohman
JACC. Cardiovascular Interventions|May 12, 2018
Should a Meta-Analysis Guide Our Practice?E Magnus Ohman, Manesh R Patel
Heart (British Cardiac Society)|December 11, 2008
ECG interpretation in ST-elevation myocardial infarction: pattern recognition or caliper measurements?Jonathan P Piccini, E Magnus Ohman
Journal of the American College of Cardiology|February 16, 2010
When can noninferior be superior? The multidimensional nature of clinical decision-making calls for innovative approaches to clinical trialsE Magnus Ohman, Robert M Califf
Lancet (London, England)|August 23, 2011
Antithrombin alternatives in STEMIGregg W Stone, E Magnus Ohman
JAMA|May 5, 2005
Drug-eluting stents in acute myocardial infarction: is science catching up with practice?Mauricio G Cohen, E Magnus Ohman
Journal of the American College of Cardiology|July 19, 2005
Improving quality of life after cardiogenic shock: do more revascularization!E Magnus Ohman, Patricia P Chang
Journal of the American College of Cardiology|August 1, 2015
The Early Invasive Strategy in Acute Coronary Syndromes: Should the Guideline Recommendations Be Revisited?Manesh R Patel, E Magnus Ohman
JACC. Cardiovascular Interventions|May 7, 2016
Should the Benefit of Transradial Access Still Be Questioned?Mauricio G Cohen, E Magnus Ohman
Nature Reviews. Cardiology|September 30, 2016
Enhancing the value of clinical trials: the role of data sharingChristopher B Granger, E Magnus Ohman
Pageof 52

Showing results (11-20 of 511) with videos related to

Sort By:
Pageof 52
JAMA|May 10, 2007
The enigma of drug-eluting stents: hope, hype, humility, and advancing patient careRobert A Harrington, E Magnus Ohman
JACC. Cardiovascular Interventions|May 12, 2018
Should a Meta-Analysis Guide Our Practice?E Magnus Ohman, Manesh R Patel
Heart (British Cardiac Society)|December 11, 2008
ECG interpretation in ST-elevation myocardial infarction: pattern recognition or caliper measurements?Jonathan P Piccini, E Magnus Ohman
Journal of the American College of Cardiology|February 16, 2010
When can noninferior be superior? The multidimensional nature of clinical decision-making calls for innovative approaches to clinical trialsE Magnus Ohman, Robert M Califf
Lancet (London, England)|August 23, 2011
Antithrombin alternatives in STEMIGregg W Stone, E Magnus Ohman
JAMA|May 5, 2005
Drug-eluting stents in acute myocardial infarction: is science catching up with practice?Mauricio G Cohen, E Magnus Ohman
Journal of the American College of Cardiology|July 19, 2005
Improving quality of life after cardiogenic shock: do more revascularization!E Magnus Ohman, Patricia P Chang
Journal of the American College of Cardiology|August 1, 2015
The Early Invasive Strategy in Acute Coronary Syndromes: Should the Guideline Recommendations Be Revisited?Manesh R Patel, E Magnus Ohman
JACC. Cardiovascular Interventions|May 7, 2016
Should the Benefit of Transradial Access Still Be Questioned?Mauricio G Cohen, E Magnus Ohman
Nature Reviews. Cardiology|September 30, 2016
Enhancing the value of clinical trials: the role of data sharingChristopher B Granger, E Magnus Ohman
Pageof 52